AnaptysBio Inc. (ANAB)
15.41
-1.41 (-8.38%)
At close: Mar 03, 2025, 12:19 PM
AnaptysBio Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 91.28M | 17.16M | 10.29M | 63.17M | 75M | 8M | 5M | 10M | 16.68M | 17.57M | 15.84M | 5.48M |
| Cost of Revenue | n/a | 2.38M | 2.33M | 98.5M | 80.03M | 99.34M | 56.2M | 29.44M | 15.42M | 17.3M | 8.61M | 8.82M |
| Gross Profit | 91.28M | 14.78M | 7.95M | -35.32M | -5.03M | -91.34M | -51.2M | -19.44M | 1.26M | 267K | 7.22M | -3.34M |
| Operating Income | -114.95M | -164.41M | -115.15M | -56.81M | -23.88M | -107.43M | -66.72M | -28.78M | -3.02M | -3.32M | 4.87M | -5.29M |
| Interest Income | 19.79M | 18.87M | 7.55M | 431K | 3.96M | 10.98M | 6.68M | 1.62M | 127K | 18K | n/a | n/a |
| Pretax Income | -145.23M | -163.62M | -128.7M | -57.8M | -19.93M | -97.49M | -61.85M | -30.07M | -4.26M | -5.27M | 3.53M | -5.54M |
| Net Income | -145.23M | -163.62M | -128.72M | -57.19M | -19.92M | -97.34M | -61.66M | -30.07M | -4.26M | -5.41M | 3.53M | -5.54M |
| Selling & General & Admin | 42.39M | 41.95M | 36.64M | 21.49M | 18.85M | 16.09M | 15.53M | 9.34M | 4.29M | 3.59M | 2.35M | 1.95M |
| Research & Development | 163.84M | 132.28M | 88.8M | 98.5M | 80.03M | 99.34M | 56.2M | 29.44M | 15.42M | 17.3M | 8.61M | 8.82M |
| Other Expenses | n/a | 7.34M | 12K | 37K | -11K | 1K | -159K | 229K | -20K | -207K | 2K | 1K |
| Operating Expenses | 206.23M | 181.57M | 125.44M | 119.99M | 98.88M | 115.43M | 71.72M | 38.78M | 19.71M | 20.89M | 10.97M | 10.77M |
| Interest Expense | -50.09M | 18.08M | 21.11M | 1.45M | n/a | 1.04M | 1.65M | 1.77M | 458K | 460K | 1.28M | 886K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 206.23M | 181.57M | 125.44M | 119.99M | 98.88M | 115.43M | 71.72M | 38.78M | 19.71M | 20.89M | 10.97M | 10.77M |
| Income Tax | -3K | -4K | 24K | -603K | -11K | -152K | -192K | 1.82M | 205K | 139K | 1.28M | 887K |
| Shares Outstanding (Basic) | 28.38M | 26.92M | 28.16M | 27.43M | 27.3M | 27.06M | 24.67M | 19.78M | 18.16M | 14.15M | 14.15M | 58.47M |
| Shares Outstanding (Diluted) | 28.38M | 26.92M | 28.16M | 27.43M | 27.3M | 27.06M | 24.67M | 19.78M | 18.16M | 14.99M | 14.99M | 59.73M |
| EPS (Basic) | -5.12 | -6.08 | -4.57 | -2.08 | -0.73 | -3.6 | -2.5 | -1.52 | -0.23 | -0.38 | 0.02 | -0.09 |
| EPS (Diluted) | -5.12 | -6.08 | -4.57 | -2.08 | -0.73 | -3.6 | -2.5 | -1.52 | -0.23 | -0.36 | 0.02 | -0.09 |
| EBITDA | -114.95M | -143.16M | -105.26M | -55.71M | -19.37M | -95.93M | -59.88M | -28.11M | -3.57M | -4.53M | 5.12M | -4.08M |
| Depreciation & Amortization | n/a | 2.38M | 2.33M | 2.09M | 559K | 514K | 315K | 183K | 233K | 274K | 308K | 580K |